Until we hear from the company, we have no formal evidence of anything. But if the facts as Dennis lays out are true, then it’s a very distinct possibility that the article is not accepted and the company’s game plan is to wait until UK approval.
Dennis never laid out any facts. He made baseless assertions.
I guarantee you there is no MHRA approval in the next half year. I will base that on the fact that the MHRA oncology committee has not yet discussed it, and that is a fact.